TD Waterhouse Canada’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

TD Waterhouse Canada’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3	Closed	-$25	–	1823
2023 Q2	$25	Hold	3	–	–	﹤0.01%	1730
2023 Q1	$15	Sell	3 -3	-50%	-$14	﹤0.01%	1732
2022 Q4	$26	Hold	6	–	–	﹤0.01%	1689
2022 Q3	$33	Hold	6	–	–	﹤0.01%	1692
2022 Q2	$42	Sell	6 -5	-45%	-$33	﹤0.01%	1728
2022 Q1	$130	Hold	11	–	–	﹤0.01%	1749
2021 Q4	$148	Buy	+11	New	+$165	﹤0.01%	1714

TD Waterhouse Canada's LMNL Position: Q3 2023 in Review

TD Waterhouse Canada sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q3 2023, closing a stake of 3 shares — an estimated $25 sold.

TD Waterhouse Canada first reported a position in LMNL in Q4 2021 and held it in 7 quarters. The position peaked at $148 in Q4 2021. 1 fund tracked by Wall St. Rank holds LMNL as of Q3 2023.

TD Waterhouse Canada reported no remaining Liminal BioSciences Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
TD Waterhouse Canada sold 3 Liminal BioSciences Inc. Common Shares shares in Q3 2023, an estimated $25.
TD Waterhouse Canada first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2021 and held it in 7 quarters.
TD Waterhouse Canada's Liminal BioSciences Inc. Common Shares position peaked at $148 in Q4 2021.
1 fund tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q3 2023.

Based on TD Waterhouse Canada's 13F filing for Q3 2023, filed 13 Nov 2023.